Prostate-specific antigen production in the female breast: Association with progesterone

Cancer Epidemiology Biomarkers and Prevention

Volumn 7, Issue 4, 1998, Pages 315-320

  Sauter, Edward R ^a   Babb, James ^a   Daly, Mary ^a   Engstrom, Paul F ^a   Ehya, Hormoz ^a   Malick, John ^a   Diamandis, Eleftherios ^b  

^a FOX CHASE CANCER CENTER   (United States)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PROGESTERONE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; ASPIRATION CYTOLOGY; BREAST CANCER; BREAST EPITHELIUM; BREAST HYPERPLASIA; CANCER RISK; CANCER SCREENING; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; MAMMOGRAPHY; NIPPLE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL;

ADULT; AGED; BIOLOGICAL MARKERS; BODY FLUIDS; BREAST; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; HYPERPLASIA; LUTEINIZING HORMONE; MIDDLE AGED; NIPPLES; PILOT PROJECTS; PROGESTERONE; PROSTATE-SPECIFIC ANTIGEN; SUCTION;

EID: 0031879075     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Luke, M. C., and Coffey, D. S. Human androgen receptor binding to the androgen response element of prostate-specific antigen. J. Androl., 15: 41-51, 1994.
2. Yu, H., Diamandis, E. P., and Sutherland, D. J. A. Immunoreactive prostatespecific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin. Biochem., 27: 75-79, 1994.
3. Yu, H, Giai, M., Diamandis, E. P., Katsaros, D., Sutherland, D. J. A., Levesque, M A., Roagna, R., Porzone, R., and Sismondi, P. Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res., 55. 2104-2110, 1995.
4. Sauter, E. R., Daly, M., Linahan, K., Ehya, H., Engstrom, P F, Bonney, G., Ross, E. A, Yu, H., and Diamandis, E. P. Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol. Biomark. Prev., 5: 967-970, 1996.
5. Petrakis, N. L. Studies on the epidemiology and natural history of benign breast disease and breast cancer using nipple aspirate fluid. Cancer Epidemiol Biomark Prev., 2: 3-10, 1993.
6. Sauter, E. R., Ross, E., Daly, M , Klein-Szanto, A., Engstrom, P. F., Sorting, A., Malick, J , and Ehya, H. Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br. J. Cancer, 76: 494-501, 1997.
7. Ferguson, R A, Yu, H., Kalyvas, M, Zammit, S., and Diamandis, E. P. Ultrasensitive detection of prostate-specific antigen by time-resolved immunofluorometric assay and the Immulite immunochemiluminescent third-generation assay potential applications in prostate and breast cancers. Clin. Chem., 42: 675-684, 1996.
8. Agresti, A. Categorical Data Analysis New York: John Wiley & Sons, Inc, 1990
9. Keynes, G Chronic mastitis Br. J Surg., 11: 89-121, 1923
10. Petrakis, N L , Mason, L., Lee, R., Sugimoto, B., Pawson, S , and Catchpool, F. Association of race, age, menopausal status, and cerumen type with breast fluid secretion in nonlactating women, as determined by nipple aspiration. J. Natl. Cancer Inst. (Bethesda), 54: 829-834, 1975.
11. King, E. B., Barrett, D., King, M C., and Petrakis, N. L Cellular composition of the nipple aspirate specimen of breast fluid I The benign cells. Am. J. Clin. Pathol, 64: 728-738, 1975.
12. Zarghami, N., Grass, L., Sauter, E. R., and Diamandis, E. P. Prostate-specific antigen levels during the menstrual cycle: possible regulation by progesterone. Clin. Chem., 43: 1862-1867, 1997.
13. Clements, A, and Mukhtar, A. Glandular kallikreins and prostate-specific antigen are expressed in the human endometrium. J. Clin. Endocrinol. Metab., 78: 1536-1539, 1994.
14. Wrensch, M. R., Petrakis, N. L., King, E B , Muke, R., Mason, L., and Chew, K. L. Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am. J. Epidemiol., 135: 130-141, 1993.
15. Petrakis, N. L., Barnes, S., King, E. B., Lowenstein, J., Wiencke, J., and Lee, M. M. Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiol. Biomark. Prev., 5: 785-794, 1996.
16. Killian, C. S., Corral, D. A., Kawinski, E., and Constantine, R I. Biochem Biophys. Res. Commun., 192: 940-947, 1993.
17. Kanety, H., Madjar, Y., Dagan, Y., Levi, J., Papa, M. I., Panente, C., Goldwasser, B., and Karasik, A. Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen. J. Clin. Endocrinol. Metab., 77: 229-233, 1993.
18. Yu, H., Diamandis, E. P., Zarghami, N., and Grass, L. Induction of prostatespecific antigen production by steroids and tamoxifen in breast cancer cell lines. Breast Cancer Res. Treat., 32: 301-310, 1994
19. Beato, M. Gene regulation by steroid hormones. Cell, 56: 335-344, 1989.
20. Giuliano, A. E. Breast. In: L. W. Way (ed.), Current Surgical Diagnosis and Treatment, pp 293-316. Norwalk, CT. Appleton & Lange, 1994.